Skip to main content

Table 1 Overall Baseline Characteristics and Comparison between rebleeding and no-rebleeding group

From: Development and validation of a model to predict rebleeding within three days after endoscopic hemostasis for high-risk peptic ulcer bleeding

Characteristic Total Rebleeding Non-rebleeding P
N = 386 N = 48 N = 338
Age, median (IQR) 56 (43–65) 54 (31.5–65) 56 (43–65) 0.229
Sex: male [No. (%)] 313 (81.1) 37 (77.1) 276 (81.7) 0.555
Alcohol use [No. (%)] 64 (16.6) 5 (10.4) 59 (17.5) 0.299
Smokers [No. (%)] 119 (30.8) 9 (18.8) 110 (32.5) 0.077
Haematemesis [No. (%)] 194 (50.3) 40 (83.3) 154 (45.6) 0.001
Medication history
 Use of NSAIDs [No. (%)] 22 (5.7) 2 (4.2) 20 (5.9) 0.875
 Use of anticoagulants [No. (%)] 4 (1) 0 4 (1.2) 1
PU bleeding history [No. (%)] 73 (18.9) 5 (10.4) 68 (20.1) 0.108
Coexisting diseases [No. (%)]
 Hypertension 90 (23.3) 10 (20.8) 80 (23.7) 0.664
 Diabetes mellitus 34 (8.8) 3 (6.3) 31 (9.2) 0.692
Shock [No. (%)] 53 (13.7) 23 (47.9) 30 (8.9) < 0.001
Systolic blood pressure [mmHg, median (IQR)] 114 (103–128) 110 (96–131.5) 114 (104–127) 0.484
Diastolic blood pressure (mmHg, mean ± SD) 70.14 ± 0.68 68.88 ± 2.37 70.32 ± 0.70 0.560
Heart rate [beats/min, median (IQR)] 86 (73–99) 99 (80.5–109.5) 85 (73–97) < 0.001
Surgery due to rebleeding [No. (%)] 15 (3.9) 15 (31.1) 0 < 0.001
Mortality [No. (%)] 16 (4.1) 16 (33.3) 0 < 0.001
Blood transfusion [No. (%)] 192 (49.7) 33 (68.8) 159 (47) 0.005
Hospitalization stay, median (IQR) 7 (5–10) 12 (7–20) 6 (5–9) < 0.001
Glasgow-Blatchford score, median (IQR) 10 (8–12) 10 (8–13) 10 (8–12) 0.138
Rockall score, median (IQR) 4 (3–4) 4 (3–5) 4 (3–4) 0.074
AIMS65 score, median (IQR) 1 (0–1) 2 (1–3) 0 (− 1) < 0.001